Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Bangladesh · Delayed Price · Currency is BDT

11.20

-0.20 (-1.75%)

At close: Aug 13, 2026

4.67% (1Y)

Market Cap	1.34B +4.7%
Revenue (ttm)	36.10M +11.7%
Net Income	-21.67M
EPS	-0.18
Shares Out	119.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	549,029
Open	11.50
Previous Close	11.40
Day's Range	11.10 - 11.50
52-Week Range	7.10 - 12.50
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablets, capsules, liquids, and ointment. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective vitamins & minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, anti-diabetic oral rehydration salt, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAID; and skin diseases, such as fungal and... [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Employees 75

Stock Exchange Dhaka Stock Exchange

Ticker Symbol CENTRALPHL

Full Company Profile

Financial Performance

In fiscal year 2025, Central Pharmaceuticals's revenue was 33.06 million, an increase of 11.68% compared to the previous year's 29.60 million. Losses were -21.98 million, -48.18% less than in 2024.

Financial Statements